BioCentury
ARTICLE | Company News

Seres Therapeutics, Mayo Clinic deal

June 13, 2016 7:00 AM UTC

Seres and Mayo Clinic’s Center for Individualized Medicine partnered to identify microbiome therapeutics for primary sclerosing cholangitis (PSC), non-alcoholic steatohepatitis (NASH) and other liver ...